Tentative cut point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 755-759

  Oda, Eiji ^a   Kawai, Ryu ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

High sensitivity C reactive protein; Inflammation; Metabolic syndrome; Obesity

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; JAPAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 65649106876     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0848     Document Type: Article

References (31)

1. Doi Y, Wakugawa Y, Kiyohara Y, Yonemoto K, Kubo M, Iwase M, et al. Elevated C-reactive protein is a predictor of diabetes in a general Japanese population: The Hisayama study. Diabetes Care 2005; 28: 2497-2500. (Pubitemid 41384300)
2. Ridker PM, Wilson PWF, Grandy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825. (Pubitemid 38780294)
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
4. Oda E, Oohara K, Abe A, Veeraveedu PT, Watanabe K, Kato K, et al. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan. Circ J 2006; 70: 384-388.
5. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: The Minoh study. Circ J 2005; 69: 386-391. (Pubitemid 40502327)
6. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Kishii R. Metabolic syndrome, C-reactive protein and increased arterial stiffness in Japanese subjects. Hypertens Res 2006; 29: 589-596. (Pubitemid 44430467)
7. Matsushita K, Yatsuya H, Tamakoshi K, Yang PO, Otsuka R, Wada K, et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk. Circ J 2007; 71: 820-825. (Pubitemid 46833917)
8. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074-1078. (Pubitemid 46998022)
9. Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007; 42: 573-582. (Pubitemid 47190075)
10. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: A statement for health care professionals [an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement]. Circulation 2005; 112: 2735-2752. (Pubitemid 41532612)
11. Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome: A new world-wide definition [consensus statement from the International Diabetes Federation]. Diabet Med 2006; 23: 469-480.
12. The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 2005; 94: 794-809 (in Japanese).
13. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607. (Pubitemid 19004941)
14. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Geneva; WHO; 1999.
15. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454. (Pubitemid 40396812)
16. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal [joint statement from the American Diabetes Association and the European Association for the Study of Diabetes]. Diabetes Care 2005; 28: 2289-2304. (Pubitemid 41242486)
17. Grundy SM. Does the metabolic syndrome exist? Diabetes Care 2006; 29: 1689-1692. (Pubitemid 44127605)
18. Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care 2006; 29: 1693-1696. (Pubitemid 44127606)
19. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247.
20. Sattar N. Why metabolic syndrome criteria have not made prime time: A view from the clinic. Int J Obes 2008; 32(Suppl 2): S30-S34.
21. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008; 31: 1283-1293.
22. Ruderman NB, Schneider SH, Berchtold P. The " metabolicallyobese", normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
23. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 2004; 109: 1955-1959. (Pubitemid 38544485)
24. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Naga N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. Am J Epidemiol 2001; 153: 1183-1190.
25. Saito I, Yonemasu K, Imai F. Association of body mass index, body fat and weight gain with inflammation markers among rural residents in Japan. Circ J 2003; 67: 323-329. (Pubitemid 36417600)
26. Nasermoaddeli A, Sekine M, Kagamimori S. Intra-individual variability of high-sensitivity C-reactive protein: Age-related variation over time in Japanese subjects. Circ J 2006; 70: 559-563.
27. Saltevo J, Vanhala M, Kautiainent H, Kumpusalo E, Laakso M. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: A population-based study. Diabet Med 2008; 25: 747-750.
28. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB Jr, et al. Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006; 152: 593-598. (Pubitemid 44233418)
29. Sato A, Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, et al. Optimal cutoff point of waist circumference and use of home blood pressure as a definition of metabolic syndrome: The Ohasama Study. Am J Hypertens 2008; 21: 514-520.
30. The Examination Committee of Criteria for "Obesity Disease" in Japan. New criteria for "obesity disease" in Japan. Circ J 2002; 66: 987-992.
31. Oda E, Watanabe K. Japanese criteria of metabolic syndrome. Circ J 2006; 70: 364.